EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2)

Hao Chi, Li Ma, Fanxing Zeng, Xiaolei Wang, Peng Peng, Xiaofei Bai, Ting Zhang, Wenhui Yin, Yaoyao Yu, Lingling Yang, Qingjun Zhou, Chao Wei und 1 weitere

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.2.15 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Hao Chi und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Qingdao, China. Hauptthemen laut MEDLINE: Graft Rejection, Corneal Transplantation, Aniline Compounds, Sulfonamides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionCorneal TransplantationAniline CompoundsSulfonamidesPeptidyl-Dipeptidase AAnimalsMiceMice, Inbred C57BLDisease Models, AnimalCellular SenescenceMice, KnockoutUp-RegulationAllograftsBlotting, WesternMice, Inbred BALB CTransplantation, HomologousGraft SurvivalMale

Substanzen

Aniline CompoundsSulfonamidesnavitoclaxPeptidyl-Dipeptidase A

Autor:innen und Institutionen

  • State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Qingdao, China.
  • Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
  • School of Ophthalmology, Shandong First Medical University, Jinan, China.
  • Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Eye Institute of Shandong First Medical University, Jinan, China.
  • Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
  • https://orcid.org/0000-0003-1581-8377.

Zitieren

APA

Chi, H., Ma, L., Zeng, F., Wang, X., Peng, P., Bai, X., Zhang, T., Yin, W., Yu, Y., Yang, L., Zhou, Q., Wei, C., & Shi, W. (2025). Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2). Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.2.15

Vancouver

Chi H, Ma L, Zeng F, Wang X, Peng P, Bai X, et al. Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2). Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.2.15

BibTeX
@article{Chi2025,
  author = {Chi, Hao and Ma, Li and Zeng, Fanxing and Wang, Xiaolei and Peng, Peng and Bai, Xiaofei and Zhang, Ting and Yin, Wenhui and Yu, Yaoyao and Yang, Lingling and Zhou, Qingjun and Wei, Chao and Shi, Weiyun},
  title = {Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2)},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.2.15}
}
Kostenlos starten →